Advanced MR Imaging in Myocarditis

Similar documents
XVth Balkan Congress of Radiology Danubius Hotel Helia, October 2017, Budapest, Hungary

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Imaging and heart failure

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

while the absence of LGE-CMR may reduce the need for ICD implantation in patients with NIDM who are at low risk for future VF/VT or SCD.

27-year-old professionnal rugby player: asymptomatic

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging

Current and Future Imaging Trends in Risk Stratification for CAD

Cardiac MRI: Cardiomyopathy

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Multiparametric T1, T2 and T2* MR Imaging

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Case based learning: CMR in Heart Failure

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Cardiac magnetic resonance imaging in rheumatoid arthritis: promising or misleading? Sophie Mavrogeni MD FESC

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Following viral myocarditis, which athlete can re-enter his active sports career?

MR imaging in suspected acute myocarditis

The use of Cardiac CT and MRI in Clinical Practice

Cardiac Sarcoidosis. Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar

Myocardial Fibrosis in Heart Failure

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

Case based learning: CMR in Heart Failure

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Role of CMR in heart failure and cardiomyopathy

Advanced Imaging MRI and CTA

Assessment Of Myocardial Viability

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Summary, conclusions and future perspectives

Association between RV Function in PPCM and LV Recovery & Clinical Outcome

Cardiac MRI: Clinical Application to Disease

MRI Sequences: What to use for what

Constrictive/Restrictive Cardiomyopathies: Diagnosis and Management Update; Radiation Induced Heart Disease. Alexander (Sandy) Dick, MD

Diastolic Function Assessment Practical Ways to Incorporate into Every Echo

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Why Cardiac MRI? Presented by:

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Restrictive Cardiomyopathy

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France

CMR stress Perfusion: what's new?

Heart Rate Recovery in association with exercise stress testing

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Acute cardiogenic shock with standing-still heart

The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

Cardiac MR Cardiac CT

Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Revascularization for Patients with HFrEF: CABG and PCI and the Concept of Myocardial Viability

Burden of Mitral Regurgitation (MR) in the US Why is This Important?

Cardiac MRI: Clinical Application to Disease

Takotsubo syndrome. Ευτυχία Σμπαρούνη, FACC, FESC

Cardiothoracic Manifestations of Connective Tissue Disease

IMR in acute STEMI and clinical outcomes

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

J. Schwitter, MD, FESC Section of Cardiology

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Typical chest pain with normal ECG

Management of Syncope in Heart Failure. University of Iowa

Current Indications for Cardiac MRI: What You See is What You Get?

Microvascular Disease: How to Diagnose and What s its Treatment

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

Spontaneous Coronary Artery Dissection

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

Conflict of Interest Disclosure

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Risk Stratification for CAD for the Primary Care Provider

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy

Welcome! To submit questions during the presentation: or Text:

Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Hypertrophic Cardiomyopathy: beyond gradient and wall thickness

Φαινόμενο No-Reflow. Απεικόνιση με CMR, κλινική συσχέτιση και προγνωστική σημασία

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

The Role of SPECT/ PET

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Outils d évaluation myocardique par relaxométrie (Myomaps)

ST2 in Heart Failure. ST2 as a Cardiovascular Biomarker. Competitive Model of ST2/IL-33 Signaling. ST2 and IL-33: Cardioprotective

What s New in Cardiac MRI

Subha V. Raman, MD, MSEE, FACC, FAHA

New Insight about FFR and IVUS MLA

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Importance of CRT team for optimization of the results: a European point of view

BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT

Imaging heart. UK Biobank Annual Meeting 13 th June 2016

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

Insights into Viability- Function and Contractile Reserve

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

Transcription:

Naeem Merchant MD FRCP Professor of Medicine Department of Radiology Department of Cardiac Sciences Cumming School of Medicine University of Calgary Advanced MR Imaging in Myocarditis

The Lake Louise Criteria Cine T2 ERE LGE

The Lake Louise Criteria Friedrich M, et al. JACC Vol. 53, No. 17, 2009 Cine LV dysfunction or pericardial effusion provides supportive evidence T2 ERE Regionally or globally elevated signal (edema) Elevated Early Relative Enhancement (hyperemia) Any 2/3 in setting of clinically suspected myocarditis LGE Non-ischemic Enhancement (necrosis)

Representative Case 1 37 yo male with chest pain, elevated troponin, no obstructive CAD on cath Cine T2 ERE LGE +55% Diagnosis: Acute Myocarditis

Representative Case 2 58 yo female with chest pain, elevated troponin, no obstructive CAD on cath Cine T2 ERE LGE Diagnosis: LAD Ischemia

Inter-site Reproducibility % positive (overall) for each site (N=35) % case agreement (N=35) Cine Site 1 Site 2 T2 BB ERE LGE T2 EE LL Criteria (2/3) LGE T2 EE LL Criteria LGE * LGE: visual presence of non-ischemic LGE * T2: T2 ratio 2 or visual presence of edema * EE: EE ratio 4 Abstract submitted - SCMR 2016 (courtesy Dr A. Howarth)

Performance of LLC Versus LV EMB Cine JACC Card Imag 2012; 5 (5) T2 BB ERE ( 14d) High PPV LGE (>14d) *Reference standard: 14 infiltrating leukocytes/mm 2 (CD3 T- lymphocytes and/or CD68 macro- phages) in addition to enhanced human leukocyte antigen class II expression in professional antigen- presenting immune cells. Poor PPV

Prognosis of T2 and ERE Cine T2 BB ERE LGE 203 patients with LGE+ Acute Myocarditis Followed for 18.9 mths for composite outcome: Cardiac death, SCA, transplant, VT, HF or recurrent myocarditis) -Occurred in 22 pts (11%) -50% of events were for recurrent myocarditis Prognostic value of OTHER CMR markers in patients with +LGE Presence of Edema: NS Presence of ERE: NS (*performed using SSFP cine) Extent of LGE: NS Baseline LVEF: Only independent predictor of MACE (HR 0.89 (0.8-0.98) Bottom line: Once LGE is seen - other markers on CMR may not be prognostic LVEF is incremental to LGE as a prognostic marker Journal of Magnetic Resonance 2015, 17:78

Performance of LGE alone 82 pts with Troponin + but normal cath Comparison of CMR vs EMB diagnosis Cine T2 BB European Heart Journal (2009) 30, 2869 2879 CMR Diagnosis EMB Diagnosis CMR based on cine and LGE imaging alone (T2 / ERE not used) ERE LGE

Prognosis of LGE alone Cine T2 BB ERE Univariate analysis: LGE+ HR 6.6 (p<0.0001) MV Analysis: LGE+ HR 2.9 (p=0.02) LVEF HR 0.97 per 1% (p=0.03) LGE Journal of Magnetic Resonance 2014, 16:14 *CMR Normal = LVEF 60% and no LGE

226 patients with biopsy-proven extra-cardiac Sarcoid Primary outcome: - Death (any cause) - Sustained ventricular arrhythmia ( 30 s or polymorphic VT), - Appropriate ICD shock

Prognosis of LGE alone - Sarcoidosis Cine T2 BB ERE LGE 153 pts with biopsy confirmed systemic sarcoid referred for exclusion of cardiac involvement Median LVEF: 63 [IQR 59-68] 11/153 patients had primary outcome: Cardiac death, Aborted SCD, Appropriate ICD Therapy Multivariable analysis: LGE+ was strongest predictor: HR 32 (p=0.0014) Neither LVEF or LVEDV was predictive J Am Coll Cardiol Img 2013;6:501 11

Improving Accuracy and Reproducibility Patients with suspected acute myocarditis 3D Strain 20 patients with clinical acute myocarditis Mean LVEF 50% 75% showed + LGE Native T2 mapping offers a robust alternative to standard T2 or LGE imaging in myocarditis T2 Mapping T1 Mapping 3D LGE Circ Cardiovasc Imaging. 2012;5:102-110

TISSUE MAPPING Infarction Bulluck H, et al Circulation Journal (2015)

Improving Accuracy and Reproducibility Patients with recently detected severe dilated cardiomyopathy 3D Strain T2 Mapping 31 patients: duration of HF 6 to 77 days Mean LVEF 30% (19-35%), LVEDVi 150 ml/m2 15/31 (48%) showed active myocarditis by EMB T2 mapping only predictor of active myocarditis T2 mapping vs EMB T1 Mapping 3D LGE Circ Cardiovasc Imaging.2015;8:e003073.

Improving Accuracy and Reproducibility Patients with suspected acute myocarditis 3D Strain T2 Mapping 50 patients suspected myocarditis 45 normal controls Mean LVEF 62 +/- 12% Assessed accuracy for differentiating the referral population from a normal population NO REFERENCE STANDARD T1 Mapping 3D LGE Emerging J Am Coll Cardiol Img 2013;6:1048 58

Improving Accuracy and Reproducibility Patients with clinically diagnosed acute myocarditis 3D Strain 165 patients with acute myocarditis +ve troponin, Flu-like illness, ECG changes, exclusion of CAD 40 normal controls T2 Mapping J Am Coll Cardiol Img 2015;8:37 46 Mean LVEF 49 +/- 15% Ability of Native T1 to supplant LGE & T2 Tested at both 1.5 and 3 Tesla T1 Mapping 3D LGE Emerging

Improving Accuracy and Reproducibility 3D Strain T2 Mapping T1 Mapping 3D LGE Emerging

PET- in Acute Myocarditis Acute Cardiac Sarcoidosis + Nuclear Imaging White JA, Rajchl, M, Bulter R, et al. Circulation 2013

Thank you www.stephensoncentre.ca